Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): A randomized, double-blind, placebo-control

Authors
Cooper M
Toto R
Zinman B
Perkovic V
Rosenstock J
Alexander J
Marx N
Pencina M
Wanner C
Baanstra D
Pfarr E
Mattheus M
Broedl U
Woerle H
George J
von E
McGuire D
Type of Publication
Journal Article
Year of Publication
2018
Journal
Cardiovascular Diabetology
DOI
10.1186/s12933-018-0682-3
Language
Eng
Volume
17
Links to full text
Search Publications
Open Publication